Huntington National Bank decreased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 22.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,783 shares of the semiconductor company’s stock after selling 5,203 shares during the period. Huntington National Bank’s holdings in Synopsys were worth $8,631,000 at the end of the most recent reporting period.
A number of other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of Synopsys by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 14,482,776 shares of the semiconductor company’s stock worth $7,029,360,000 after buying an additional 120,575 shares in the last quarter. State Street Corp lifted its stake in shares of Synopsys by 1.7% during the third quarter. State Street Corp now owns 6,948,473 shares of the semiconductor company’s stock valued at $3,518,637,000 after buying an additional 119,057 shares during the period. Geode Capital Management LLC boosted its position in Synopsys by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 3,357,165 shares of the semiconductor company’s stock worth $1,625,230,000 after acquiring an additional 75,298 shares during the last quarter. Pictet Asset Management Holding SA grew its stake in Synopsys by 3.5% in the 4th quarter. Pictet Asset Management Holding SA now owns 1,758,759 shares of the semiconductor company’s stock worth $853,631,000 after acquiring an additional 60,121 shares during the period. Finally, Norges Bank acquired a new position in Synopsys in the 4th quarter valued at $583,608,000. 85.47% of the stock is owned by institutional investors and hedge funds.
Synopsys Price Performance
NASDAQ:SNPS opened at $438.55 on Thursday. Synopsys, Inc. has a 1-year low of $422.65 and a 1-year high of $624.80. The stock has a market cap of $67.81 billion, a P/E ratio of 30.20, a PEG ratio of 3.23 and a beta of 1.16. The firm has a 50-day moving average of $479.67 and a two-hundred day moving average of $504.45.
Insider Activity at Synopsys
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on SNPS. Needham & Company LLC reaffirmed a “buy” rating and issued a $650.00 price objective on shares of Synopsys in a research report on Thursday, February 27th. Morgan Stanley lowered their price target on Synopsys from $625.00 to $590.00 and set an “overweight” rating for the company in a report on Monday, February 24th. Piper Sandler cut their price objective on shares of Synopsys from $655.00 to $653.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Rosenblatt Securities reissued a “buy” rating and issued a $660.00 target price on shares of Synopsys in a research report on Tuesday, February 25th. Finally, Robert W. Baird dropped their price target on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. One research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $638.58.
Check Out Our Latest Report on Synopsys
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- Manufacturing Stocks Investing
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- The 3 Most Talked About Investments on WallStreetBets Right Now
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Analyst Targets Signal More Growth in CrowdStrike Stock
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.